The FDA Rejects New Drug for SR-aGVHD, Shocking Scientists and Patients
source: pixabay.com

The FDA Rejects New Drug for SR-aGVHD, Shocking Scientists and Patients

As reported in BioSpace, the FDA shocked Mesoblast executives, a stem-cell research company, when this October, they rejected the Biologics License Application (BLA) for the drug Ryoncil, meant to treat…

Continue Reading The FDA Rejects New Drug for SR-aGVHD, Shocking Scientists and Patients
New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen
source: pixabay.com

New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen

A recent study has found a 12.5% improvement for patients with severe COVID-19 when baricitinib was used in combination with remdesivir. That means a faster recovery time for patients and…

Continue Reading New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen
Air Pollution Worsens COVID-19 Severity, Death Rate
https://pixabay.com/photos/industry-sunrise-fog-germany-611668/

Air Pollution Worsens COVID-19 Severity, Death Rate

Arguably, our entire year has been dominated by discussions of COVID-19, a novel coronavirus resulting in 28.3 million cases and 911,000 deaths across the globe. In the United States alone,…

Continue Reading Air Pollution Worsens COVID-19 Severity, Death Rate

 Researchers Are Studying the Use of THC For the Treatment of ARDS caused by COVID-19

According to a recent article in Genetic Engineering & Biotechnology News, researchers at the UofSC have presented data stating that the cannabis compound tetrahydrocannabinol (THC) is effective against respiratory distress syndrome…

Continue Reading  Researchers Are Studying the Use of THC For the Treatment of ARDS caused by COVID-19
Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
source: pixabay.com

Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients

by Danielle Bradshaw from In The Cloud Copy Information provided by the Michael J. Fox Foundation showed that the majority of patients that had Parkinson’s disease and also contracted COVID-19…

Continue Reading Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
How COVID-19, Chronic Fatigue Syndrome, and Guillain-Barre Syndrome are Linked
source: pixabay.com

How COVID-19, Chronic Fatigue Syndrome, and Guillain-Barre Syndrome are Linked

We have learned a lot, but still have much to learn about COVID-19. Researchers have seen a link between COVID-19 and chronic fatigue syndrome (myalgic encephalomyelitis) as well as Guillain-Barre syndrome, which…

Continue Reading How COVID-19, Chronic Fatigue Syndrome, and Guillain-Barre Syndrome are Linked
Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19
source: pixabay.com

Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19

Parkinson’s UK is nonprofit organization striving to help Parkinson's disease research continue amidst this global pandemic. Their goal is to get clinical research, and specifically studies that necessitate patients participating…

Continue Reading Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19